The firm said it raised its price target on the healthcare company as it believes Humana will be able to trade at 16x its full year 2015 earnings per share guidance.
For fiscal 2015 Credit Suisse has estimated for earnings per share of $8.75. For the 2016 full fiscal year Credit Suisse forecasts for earnings of $9.80 per share.
Must Read: Warren Buffett's 25 Favorite Stocks
The firm has a "neutral" rating on Humana stock.
Shares of Humana are higher by 1.09% to $132 in pre-market trading this morning.
Separately, TheStreet Ratings team rates HUMANA INC as a Buy with a ratings score of B+. TheStreet Ratings Team has this to say about their recommendation:
"We rate HUMANA INC (HUM) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income."